Steady-state is the plateau where the amount going in each interval equals the amount clearing out.
Accumulation happens because each dose lands before the previous one has fully cleared, so leftovers stack.
It takes about five half-lives of consistent dosing to reach ~97% of the plateau — the same timescale that clears one dose.
For a weekly compound with a multi-day half-life, that ramp is several weeks, not days.
Early doses sit on a rising curve, so levels are not representative of the eventual plateau yet.
When a compound is dosed repeatedly before the previous dose has cleared, the leftovers stack. Steady-state is the plateau where the amount going in each interval equals the amount clearing out — accumulation stops rising and levels off.
In plain terms: it is the point where "topping up" and "draining away" finally balance.
Fig. Weekly dosing accumulates: each semaglutide dose lands before the previous has cleared, so levels build toward a plateau (steady-state) over roughly five half-lives. Single-dose decay (grey) versus repeated weekly dosing (gradient). An illustrative model from the published half-life, not a measurement.
Why accumulation happens
If a dose is given every half-life, half of it is still present when the next arrives. Dose two builds on that residue, dose three on the combined residue, and so on. But each addition is smaller relative to the growing total, so the curve rises toward a ceiling rather than climbing forever1.
In plain terms: you are filling a leaky bucket. Early on, you add faster than it drains and the level climbs. Eventually the leak (proportional to how full it is) matches the pour, and the level holds.
The five-half-lives rule, in reverse
The same timescale that clears one dose — about five half-lives — is how long rising accumulation takes to reach roughly 97% of its plateau1. For a compound with a multi-day half-life dosed weekly, that is a multi-week ramp before levels stabilise.
Time in consistent dosing
Approx. of eventual plateau
1 half-life
~50%
2 half-lives
~75%
3 half-lives
~88%
4 half-lives
~94%
5 half-lives
~97%
A real example: semaglutide's ~7-day half-life means levels build over roughly five weeks of once-weekly dosing before flattening2.
Why it matters for interpreting a protocol
Early doses sit on a rising curve; levels are not representative of the plateau yet.
A dose change takes about five half-lives to fully express in the new steady-state.
Missing a dose during the ramp has a different effect than missing one at plateau.
This is why a level view that models accumulation — not just single doses — is more informative than a static "half-life = X" figure. Zyra Labs plots the accumulating curve from the doses you actually log, as information rather than instruction.
Roughly five half-lives of consistent dosing — the same timescale over which a single dose clears. For a weekly compound with a multi-day half-life, that can be several weeks.
Does steady-state mean levels stop changing?
It means the peaks and troughs stop rising overall. Levels still rise and fall between each dose, but the pattern repeats around a stable average instead of climbing higher each week.
Why do levels keep climbing for weeks on a fixed dose?
Because each dose lands before the last has fully cleared, the residue stacks. The stacking shrinks with each dose relative to the growing total, so the curve rises toward a ceiling and then flattens rather than climbing forever.
References
Rowland M, Tozer TN. Clinical Pharmacokinetics and Pharmacodynamics: Concepts and Applications (4th ed.).Lippincott Williams & Wilkins. 2011. ISBN 978-0-7817-5009-7
Overgaard RV, Delff PH, Petri KCC, et al. Population Pharmacokinetics of Semaglutide for Type 2 Diabetes.Diabetes Ther. 2019. DOI 10.1007/s13300-019-0581-y
Zyra Labs is a research and educational utility. Nothing on this page is medical advice, a dosing recommendation, or an endorsement of any compound. We never sell or source compounds and refuse sourcing questions. Consult a qualified clinician for decisions about your health.